BIOPROP20: Biologically optimised IMRT for prostate radiotherapy

• Research type

  Research Study

• Full title

  BIOPROP 20: Biologically optimised IMRT for Prostate Radiotherapy Hypofractionated radiotherapy with intra-prostatic boosts to tumour nodules in men with intermediate and high risk prostate cancer

• IRAS ID

  71578

• Contact name

  Isabel Syndikus

• Contact email

  Isabel.Syndikus@clatterbridgecc.nhs.uk

• Sponsor organisation

  The Clatterbridge Cancer Centre NHS Foundation Trust

• REC name

  North West - Greater Manchester East Research Ethics Committee

• REC reference

  13/NW/0100

• Date of REC Opinion

  22 Feb 2013

• REC opinion

  Favourable Opinion